Cyber Monday Deal: Up to 60% off InvestingProCLAIM SALE

Mystery package was flu treatment, says Team Sky boss Brailsford

Published 19/12/2016, 16:03
© Reuters. Team Sky rider manager Dave Brailsford waits for the start of the 6th stage of the 102nd Tour de France cycling race from Abbeville to Le Havre

LONDON (Reuters) - The mystery package at the centre of a UK Anti-Doping investigation into British Cycling contained a flu treatment, Team Sky chief Dave Brailsford told Members of Parliament on Monday.

British Cycling and Team Sky have been under scrutiny over the package delivered to the 2011 Criterium du Dauphine in which Bradley Wiggins was riding.

Wiggins' then coach Shane Sutton, giving evidence to a Parliamentary inquiry into doping in sport, earlier said he did not know what the package contained. The chair of British Cycling's Ethics Commission George Gilbert said it could have been pedals.

Brailsford shed more light on the situation, however, after he said he had been given permission to do so by United Kingdom Anti-Doping which is investigating allegations of wrongdoing in the sport.

He said Team Sky doctor Richard Freeman had told him it was Fluimucil - a product to treat coughs and sore throats.

"Doctor Freeman told me that it was Fluimucil that was in the package, a product that is for a nebuliser. That is what was in the package," Brailsford told MPs.

Brailsford repeated Sutton's comment that British Cycling coach Simon Cope had brought the package with him on a pre-planned logistical trip.

Admitting he was "pained" by the shadow cast over British Cycling by the investigation, Brailsford said the package had only recently been brought to his attention.

"Let's just be clear, I wasn't aware of the package at the time. When it was brought to my attention, it is my role to take those matters seriously to try and gather the facts and see if there was any need for a disciplinary procedure," he said.

"My first course of action was to speak to all of the guys on the team. I got witness statements, and then I couldn't see that there was any anti-doping rule violation.

"However, I also felt that it was probably appropriate to pass that on and have it viewed by an independent authority who could verify the fact."

Asked why Team Sky had flown out the Fluimucil, a permitted drug on the WADA list, rather than buy it locally, Brailsford acknowledged that it did seem "extreme" but said it was normal to get supplies from their own stock in Britain.

Brailsford said Team Sky regularly gave Fluimucil to their riders to treat colds.

"As a cycling team we are constantly moving around late at night. (Simon) was on his way anyway and brought it down with him. He has his own stores in Manchester so brought it with him. That was the decision made and I totally understand it."

Sutton had earlier said it was not his job to know what medication 2012 Tour de France winner Wiggins was taking.

© Reuters. Team Sky rider manager Dave Brailsford waits for the start of the 6th stage of the 102nd Tour de France cycling race from Abbeville to Le Havre

"Never even thought to ask," Sutton said. "I know Brad was suffering towards the end of the Dauphine."

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.